pre-ipo
Stage
About
argenx is a clinical-stage biotechnology company that develops differentiated antibody therapies for the treatment of severe autoimmune diseases and cancer.
Explore argenx ADR's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.